MEDIUM confidence: 100% data completeness, but the composite (33) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Low explanatory power (R² 0.09) — the factor model explains little of this stock's return variation, so these exposures are noisy. Interpret with caution.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-19.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0— | $428Kn/m | $645K+50.9% | $3M+413.0% | $6M+84.1% |
| EPS (dil.) | $-0.00— | $-0.01n/m | $-0.01n/m | $-0.01n/m | $1.34n/m |
| Free Cash Flow | -$504K— | -$4Mn/m | -$1Mn/m | -$105Kn/m | -$5Mn/m |
| Gross Margin | — | -30.2% | 34.5%+64.6pp | 23.0%-11.5pp | 5.1%-17.9pp |
| Operating Margin | — | -400.8% | -373.9%+26.9pp | -73.9%+300.0pp | 7288.1%+7362.1pp |
| Net Margin | — | -468.9% | -382.0%+86.9pp | -99.5%+282.5pp | 5719.1%+5818.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 100% → 100% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $-0.04 | $-0.15 | -275.0% |
| Apr 2026 | $0.18 | $0.09 | -52.8% |
| Jan 2026 | $0.15 | $-15.98 | -10753.3% |
| Nov 2025 | $-0.10 | $13.62 | +13720.0% |
| Jul 2025 | $-0.31 | $-0.31 | +0.0% |
| Apr 2025 | — | $-0.01 | — |
| Jan 2025 | — | $-0.00 | — |
| Dec 2024 | — | $-0.00 | — |
Net insider $15K over 180 days (2 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
The QScore of 33 for BMNR indicates a relatively weak overall assessment, driven down by low scores in Value and Profitability, with the latter exhibiting extremely negative operating margins and return on equity. In contrast, the stock scores high on Growth, with notable revenue and EPS growth rates. The short-term score is slightly higher than the long-term score, but the divergence is not significant. BMNR trades at a premium to its financials, with negative price multiples, and exhibits strong growth but poor profitability and high volatility.